Ballast Inc. Sells 105 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ballast Inc. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,609 shares of the healthcare conglomerate’s stock after selling 105 shares during the quarter. UnitedHealth Group comprises about 2.3% of Ballast Inc.’s holdings, making the stock its 14th biggest holding. Ballast Inc.’s holdings in UnitedHealth Group were worth $6,638,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of UNH. Keebeck Wealth Management LLC grew its position in UnitedHealth Group by 11.6% in the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock worth $5,185,000 after purchasing an additional 1,122 shares during the period. Ascension Capital Advisors Inc. purchased a new position in UnitedHealth Group in the third quarter worth about $216,000. Physician Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $207,000. Bartlett & Co. LLC lifted its stake in shares of UnitedHealth Group by 5.7% during the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after buying an additional 8,873 shares in the last quarter. Finally, Great Valley Advisor Group Inc. raised its holdings in UnitedHealth Group by 5.8% during the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after acquiring an additional 1,884 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $494.70 on Friday. The stock has a market capitalization of $456.08 billion, a PE ratio of 20.75, a PEG ratio of 1.34 and a beta of 0.54. The company has a 50 day moving average price of $503.10 and a 200-day moving average price of $518.61. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.34 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on UNH shares. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 29th. Truist Financial restated a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Thursday, November 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 19th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.